Citius Pharmaceuticals Inc (CTXR)
0.6602
-0.07
(-9.88%)
USD |
NASDAQ |
Apr 26, 16:00
0.6648
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Total Liabilities (Quarterly): 12.07M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 12.07M |
September 30, 2023 | 12.18M |
June 30, 2023 | 12.10M |
March 31, 2023 | 12.43M |
December 31, 2022 | 10.67M |
September 30, 2022 | 10.57M |
June 30, 2022 | 9.980M |
March 31, 2022 | 9.59M |
December 31, 2021 | 12.96M |
September 30, 2021 | 9.646M |
June 30, 2021 | 9.311M |
March 31, 2021 | 8.904M |
December 31, 2020 | 9.511M |
September 30, 2020 | 10.10M |
June 30, 2020 | 9.658M |
March 31, 2020 | 4.049M |
December 31, 2019 | 4.606M |
September 30, 2019 | 9.594M |
June 30, 2019 | 4.038M |
March 31, 2019 | 3.361M |
December 31, 2018 | 3.900M |
September 30, 2018 | 3.185M |
June 30, 2018 | 2.190M |
March 31, 2018 | 2.562M |
December 31, 2017 | 2.617M |
Date | Value |
---|---|
September 30, 2017 | 2.469M |
June 30, 2017 | 9.973M |
March 31, 2017 | 7.342M |
December 31, 2016 | 6.319M |
September 30, 2016 | 5.184M |
June 30, 2016 | 4.854M |
March 31, 2016 | 4.353M |
December 31, 2015 | 1.937M |
September 30, 2015 | 1.377M |
June 30, 2015 | 2.143M |
March 31, 2015 | 1.684M |
December 31, 2014 | 1.646M |
September 30, 2014 | 2.299M |
June 30, 2014 | 0.0314M |
March 31, 2014 | 0.0251M |
December 31, 2013 | 0.021M |
September 30, 2013 | 0.0147M |
June 30, 2013 | 0.062M |
March 31, 2013 | 0.0576M |
December 31, 2012 | 0.0474M |
September 30, 2012 | 0.046M |
June 30, 2012 | 0.0406M |
March 31, 2012 | 0.0336M |
December 31, 2011 | 0.0266M |
September 30, 2011 | 0.0241M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.038M
Minimum
Jun 2019
12.96M
Maximum
Dec 2021
9.578M
Average
9.658M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
QuidelOrtho Corp | 3.557B |
TransCode Therapeutics Inc | 3.529M |
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 97.40M |
Shareholders Equity (Quarterly) | 84.73M |